| | 成交量 | : 212,769 | | 平均成交(3個月) | : 466,509 |
| P/E (ttm) | :
N/A | | 市值 | :
4.53M | | 每股盈利 (ttm) | :
-0.037 | | 股息及溢利 | : N/A | | 每手股數 | : N/A |
| 今日波幅 | : 0.081 - 0.087 | | 52週波幅 | : 0.010 - 0.320 |
|
公司新聞 | 更多 | | 2009年11月22日 (星期日) | | 02:04 | XENACARE HOLDINGS, INC. Financials (EDGAR Online Financials) | | 2009年11月17日 (星期二) | | 03:37 | XENACARE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online) | | 2009年11月4日 (星期三) | | 21:00 | XenaCare Holdings Announces Availability of Cobroxin through the Chain Drug Marketing Association (CDMA) (Business Wire) | | 2009年10月22日 (星期四) | | 21:00 | XenaCare Holdings Announces Agreement to Market its Over-the-Counter Pain Reliever, Cobroxin, in the Official Annual Publication of NASCAR (Business Wire) | | 2009年10月20日 (星期二) | | 21:00 | XenaCare Holdings Announces Agreement to Market OTC Pain Reliever, Cobroxin, in the National Football League (NFL) Alumni Association Publication (Business Wire) | | 2009年10月14日 (星期三) | | 21:00 | Nutra Pharma Announces Online Availability of Cobroxin for the Treatment of Moderate to Severe Chronic Pain (Business Wire) | | 2009年10月3日 (星期六) | | 02:15 | XENACARE HOLDINGS, INC. Files SEC form 10-Q/A, Quarterly Report (EDGAR Online) | | 2009年10月2日 (星期五) | | 23:35 | Nutra Pharma Announces Manufacturing Release of Cobroxin, a Treatment for Chronic Pain (Business Wire) | | 2009年9月21日 (星期一) | | 21:00 | Nutra Pharma Announces Plans to Begin Drug Registration Process in Canada and Europe for its Over-the-Counter Pain Reliever (Business Wire) | | 2009年9月3日 (星期四) | | 21:00 | XenaCare Holdings Announces National Print Advertising Campaign for Cobroxin, a Treatment for Moderate to Severe (Stage 2) Pain (Business Wire) |
|
|
